相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Argatroban dosing requirements in extracorporeal life support and other critically ill populations
J. Spencer Dingman et al.
THROMBOSIS RESEARCH (2020)
Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis
Christopher Kabrhel et al.
ACADEMIC EMERGENCY MEDICINE (2019)
Imminent risk of a global shortage of heparin caused by the African Swine Fever afflicting the Chinese pig herd
Eduardo Vilanova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery
Andreas Koster et al.
ANESTHESIOLOGY (2018)
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes
Giuseppe Gargiulo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Bivalirudin versus heparin in percutaneous coronary intervention-a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb/IIIa strategy
Mahesh Anantha-Narayanan et al.
JOURNAL OF THORACIC DISEASE (2018)
ASHP guidelines on managing drug product shortages
Erin R. Fox et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2018)
Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery
Saraschandra Vallabhajosyula et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
Holger J. Schunemann et al.
BLOOD ADVANCES (2018)
A META-ANALYSIS OF BIVALIRUDIN VERSUS ARGATROBAN FOR THE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA
Harold Rivner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force
John U. Doherty et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Heparin-Induced Thrombocytopenia A Comprehensive Clinical Review
Benjamin S. Salter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia
Cornelius Keyl et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
M. Valgimigli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: Comparison of clinical outcomes
Erik E. Abel et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Susan R. Kahn et al.
CHEST (2012)
Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Lori-Ann Linkins et al.
CHEST (2012)
OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT FOR REFRACTORY CARDIOGENIC SHOCK IN THE ERA OF MORE ADVANCED VENTRICULAR ASSIST DEVICES
Hiroo Takayama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia
Tyree H. Kiser et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Bivalirudin Dosing Adjustments for Reduced Renal Function With or Without Hemodialysis in the Management of Heparin-Induced Thrombocytopenia
Laura V. Tsu et al.
ANNALS OF PHARMACOTHERAPY (2011)
Correlation of Bivalirudin Dose with Creatinine Clearance During Treatment of Heparin-Induced Thrombocytopenia
Courtney L. Runyan et al.
PHARMACOTHERAPY (2011)
Argatroban Dosage Requirements and Outcomes in Intensive Care versus Non-Intensive Care Patients
Maureen A. Smythe et al.
PHARMACOTHERAPY (2009)
Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia
Lawrence Rice et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Argatroban anticoagulation in critically ill patients
Martin Beiderlinden et al.
ANNALS OF PHARMACOTHERAPY (2007)
Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia
TH Kiser et al.
PHARMACOTHERAPY (2005)
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia
BE Lewis et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Excessive argatroban anticoagulation for heparin-induced thrombocytopenia
MG Reichert et al.
ANNALS OF PHARMACOTHERAPY (2003)
分享论文
